AIDS treatment with novel anti-HIV compounds improved by nanotechnology - 文章详情页

作者：

收录：

Scopus

摘要：

The　first　International　Symposium　of　Nanomedicine　on　AIDS　＂AIDS　Treatment　with　Novel　Anti-HIV　compounds　Improved　by　Nanotechnology＂　was　held　November　19-20,　2009　in　Beijing,　China.　This　symposium　provided　an　international　forum　for　presentation　and　discussion　of　exciting　new　advances　in　the　emerging　research　area　of　nanobiomedical　research　on　AIDS　treatment　as　the　focus　point,　as　well　as　some　issues　in　relevant　fields　such　as　nanobiomedical　research　on　tumor　treatment　and　safety　evaluation　of　nanomedicines.　Key　highlights　of　the　symposium　include　(1)　reviewing　current　status　of　nanobiotechnology　programs　and　their　relations,　more　or　less,　with　AIDS　treatment;　(2)　reviewing　current　AIDS　epidemiology　in　China　and　examining　effectiveness　and　efficiency　of　current　prevention　and　treatment　strategies;　(3)　highlighting　the　obstacles　to　improve　AIDS　prevention　and　treatment,　and　(4)　exploring　innovative　ways　for　nanotechnology　to　advance　AIDS　treatment,　especially　to　combat　HIV　resistance　to　drugs.　©　2010　American　Association　of　Pharmaceutical　Scientists.

关键词：

AIDS treatment; anti-AIDS drug development; nanomedicine; nanotechnology

作者机构：

[ 1 ] [Ma, X.]Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, Beijing, China
[ 2 ] [Ma, X.]CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, Beijing 100190, China
[ 3 ] [Wang, D.]Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, Beijing, China
[ 4 ] [Wang, D.]CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, Beijing 100190, China
[ 5 ] [Wu, Y.]Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, Beijing, China
[ 6 ] [Wu, Y.]CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, Beijing 100190, China
[ 7 ] [Ho, R.J.Y.]Department of Pharmaceutics, University of Washington, Seattle, WA 98105, United States
[ 8 ] [Jia, L.]Developmental Therapeutics Program, National Cancer Institute, NIH, Bethesda, MD 20892, United States
[ 9 ] [Guo, P.]Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45208, United States
[ 10 ] [Hu, L.]College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China
[ 11 ] [Xing, G.]Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
[ 12 ] [Zeng, Y.]College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China
[ 13 ] [Zeng, Y.]Department of Oncogenic Virus and HIV/AIDS, Institute for Control and Prevention of Viral Disease, China CDC, Beijing 102206, China
[ 14 ] [Liang, X.-J.]Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, Beijing, China
[ 15 ] [Liang, X.-J.]CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, Beijing 100190, China

通讯作者信息：

[Liang, X.-J.]Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, Beijing, China

电子邮件地址：

liangxj@nanoctr.cn

查看成果更多字段

成果类型
所属机构

所有年份指定年份从至